SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS
The invention relates to substituted imidazo pyrimidine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FOLLMANN, Markus MÜLLER, Steffen POOK, Elisabeth CANDISH, Lisa GAUGAZ, Fabienne GERDES, Christoph BUCHMÜLLER, Anja SÜSSMEIER, Frank SCHOHE-LOOP, Rudolf LANG, Dieter |
| description | The invention relates to substituted imidazo pyrimidine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders. These compounds are EP3 antagonists.
L'invention concerne des dérivés d'imidazo pyrimidine substitués et des procédés pour leur préparation, ainsi que leur utilisation pour la préparation de médicaments pour le traitement et/ou la prophylaxie de maladies, en particulier de troubles cardiovasculaires, de préférence de troubles thrombotiques ou thromboemboliques, et du diabète, ainsi que de troubles urogénitaux et ophtalmiques. Ces composés sont des antagonistes EP3. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021094208A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021094208A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021094208A13</originalsourceid><addsrcrecordid>eNrjZNALDnUKDvEMCQ1xdVHw9PV0cYzyVwiIDAIxPf1cFVwDjBUc_UIc3f39PINDgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkaGBpYmRgYWjoTFxqgCjSyb3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS</title><source>esp@cenet</source><creator>FOLLMANN, Markus ; MÜLLER, Steffen ; POOK, Elisabeth ; CANDISH, Lisa ; GAUGAZ, Fabienne ; GERDES, Christoph ; BUCHMÜLLER, Anja ; SÜSSMEIER, Frank ; SCHOHE-LOOP, Rudolf ; LANG, Dieter</creator><creatorcontrib>FOLLMANN, Markus ; MÜLLER, Steffen ; POOK, Elisabeth ; CANDISH, Lisa ; GAUGAZ, Fabienne ; GERDES, Christoph ; BUCHMÜLLER, Anja ; SÜSSMEIER, Frank ; SCHOHE-LOOP, Rudolf ; LANG, Dieter</creatorcontrib><description>The invention relates to substituted imidazo pyrimidine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders. These compounds are EP3 antagonists.
L'invention concerne des dérivés d'imidazo pyrimidine substitués et des procédés pour leur préparation, ainsi que leur utilisation pour la préparation de médicaments pour le traitement et/ou la prophylaxie de maladies, en particulier de troubles cardiovasculaires, de préférence de troubles thrombotiques ou thromboemboliques, et du diabète, ainsi que de troubles urogénitaux et ophtalmiques. Ces composés sont des antagonistes EP3.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210520&DB=EPODOC&CC=WO&NR=2021094208A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210520&DB=EPODOC&CC=WO&NR=2021094208A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FOLLMANN, Markus</creatorcontrib><creatorcontrib>MÜLLER, Steffen</creatorcontrib><creatorcontrib>POOK, Elisabeth</creatorcontrib><creatorcontrib>CANDISH, Lisa</creatorcontrib><creatorcontrib>GAUGAZ, Fabienne</creatorcontrib><creatorcontrib>GERDES, Christoph</creatorcontrib><creatorcontrib>BUCHMÜLLER, Anja</creatorcontrib><creatorcontrib>SÜSSMEIER, Frank</creatorcontrib><creatorcontrib>SCHOHE-LOOP, Rudolf</creatorcontrib><creatorcontrib>LANG, Dieter</creatorcontrib><title>SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS</title><description>The invention relates to substituted imidazo pyrimidine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders. These compounds are EP3 antagonists.
L'invention concerne des dérivés d'imidazo pyrimidine substitués et des procédés pour leur préparation, ainsi que leur utilisation pour la préparation de médicaments pour le traitement et/ou la prophylaxie de maladies, en particulier de troubles cardiovasculaires, de préférence de troubles thrombotiques ou thromboemboliques, et du diabète, ainsi que de troubles urogénitaux et ophtalmiques. Ces composés sont des antagonistes EP3.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNALDnUKDvEMCQ1xdVHw9PV0cYzyVwiIDAIxPf1cFVwDjBUc_UIc3f39PINDgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkaGBpYmRgYWjoTFxqgCjSyb3</recordid><startdate>20210520</startdate><enddate>20210520</enddate><creator>FOLLMANN, Markus</creator><creator>MÜLLER, Steffen</creator><creator>POOK, Elisabeth</creator><creator>CANDISH, Lisa</creator><creator>GAUGAZ, Fabienne</creator><creator>GERDES, Christoph</creator><creator>BUCHMÜLLER, Anja</creator><creator>SÜSSMEIER, Frank</creator><creator>SCHOHE-LOOP, Rudolf</creator><creator>LANG, Dieter</creator><scope>EVB</scope></search><sort><creationdate>20210520</creationdate><title>SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS</title><author>FOLLMANN, Markus ; MÜLLER, Steffen ; POOK, Elisabeth ; CANDISH, Lisa ; GAUGAZ, Fabienne ; GERDES, Christoph ; BUCHMÜLLER, Anja ; SÜSSMEIER, Frank ; SCHOHE-LOOP, Rudolf ; LANG, Dieter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021094208A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FOLLMANN, Markus</creatorcontrib><creatorcontrib>MÜLLER, Steffen</creatorcontrib><creatorcontrib>POOK, Elisabeth</creatorcontrib><creatorcontrib>CANDISH, Lisa</creatorcontrib><creatorcontrib>GAUGAZ, Fabienne</creatorcontrib><creatorcontrib>GERDES, Christoph</creatorcontrib><creatorcontrib>BUCHMÜLLER, Anja</creatorcontrib><creatorcontrib>SÜSSMEIER, Frank</creatorcontrib><creatorcontrib>SCHOHE-LOOP, Rudolf</creatorcontrib><creatorcontrib>LANG, Dieter</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FOLLMANN, Markus</au><au>MÜLLER, Steffen</au><au>POOK, Elisabeth</au><au>CANDISH, Lisa</au><au>GAUGAZ, Fabienne</au><au>GERDES, Christoph</au><au>BUCHMÜLLER, Anja</au><au>SÜSSMEIER, Frank</au><au>SCHOHE-LOOP, Rudolf</au><au>LANG, Dieter</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS</title><date>2021-05-20</date><risdate>2021</risdate><abstract>The invention relates to substituted imidazo pyrimidine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders. These compounds are EP3 antagonists.
L'invention concerne des dérivés d'imidazo pyrimidine substitués et des procédés pour leur préparation, ainsi que leur utilisation pour la préparation de médicaments pour le traitement et/ou la prophylaxie de maladies, en particulier de troubles cardiovasculaires, de préférence de troubles thrombotiques ou thromboemboliques, et du diabète, ainsi que de troubles urogénitaux et ophtalmiques. Ces composés sont des antagonistes EP3.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021094208A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A10%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FOLLMANN,%20Markus&rft.date=2021-05-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021094208A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |